drugset / Trial / NCT06643390
A Study of MK-2225 in Healthy Participants (MK-2225-003)
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of the study is to learn about the safety of MK-2225, including how well people tolerate it. Researchers also want to learn what happens to different doses of MK-2225 in a person's body over time.
Timeline
- Start
- 2023-11-21
- Primary completion
- 2025-07-14
- Completion
- 2025-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-2225 | Unknown | — | Subcutaneous |